Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Technology | 14.35% |
| 3 | Financials | 11.23% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Real Estate | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Alaunos Therapeutics
TCRT
$4.79M
| $1.2M | ﹤0.01% |
+1,375
| New | +$946K |
|
2602
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $1.2M | ﹤0.01% |
8,400
+4,100
| +95% | +$567K |
|
|
BEDU
2603
DELISTED
Bright Scholar Education Holdings
BEDU
| $1.2M | ﹤0.01% |
33,075
+20,025
| +153% | +$849K |
|
2604
TETRA Technologies
TTI
$1.25B
| $1.2M | ﹤0.01% |
735,186
+282,316
| +62% | +$569K |
|
|
DNBF
2605
DELISTED
DNB Financial Corp
DNBF
| $1.19M | ﹤0.01% |
26,800
+8,275
| +45% | +$341K |
|
|
CDOR
2606
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
| $1.19M | ﹤0.01% |
131,415
+10,090
| +8% | +$96.1K |
|
|
COWN
2607
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.19M | ﹤0.01% |
69,050
-13,878
| -17% | -$224K |
|
2608
Immersion
IMMR
$250M
| $1.19M | ﹤0.01% |
155,713
+109,113
| +234% | +$921K |
|
|
VSI
2609
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.18M | ﹤0.01% |
299,300
-75,900
| -20% | -$392K |
|
2610
Beazer Homes USA
BZH
$873M
| $1.18M | ﹤0.01% |
122,300
-177,860
| -59% | -$1.94M |
|
2611
WisdomTree India Earnings Fund ETF
EPI
$2.03B
| $1.17M | ﹤0.01% |
+44,800
| New | +$1.16M |
|
|
TBRG
2612
DELISTED
TruBridge
TBRG
| $1.17M | ﹤0.01% |
41,976
+21,576
| +106% | +$603K |
|
2613
Invesco Preferred ETF
PGX
$3.77B
| $1.17M | ﹤0.01% |
79,700
-187,045
| -70% | -$2.73M |
|
2614
Merchants Bancorp
MBIN
$2.53B
| $1.17M | ﹤0.01% |
+102,600
| New | +$1.41M |
|
|
ALO
2615
DELISTED
Alio Gold Inc
ALO
| $1.16M | ﹤0.01% |
1,489,353
+124,971
| +9% | +$82.1K |
|
|
SACH
2616
Sachem Capital Corp
SACH
$38.1M
| $1.16M | ﹤0.01% |
218,200
+167,916
| +334% | +$813K |
|
|
GBL
2617
DELISTED
GAMCO Investors, Inc.
GBL
| $1.15M | ﹤0.01% |
60,100
+36,300
| +153% | +$714K |
|
2618
Unity Bancorp
UNTY
$622M
| $1.15M | ﹤0.01% |
50,709
-11,392
| -18% | -$238K |
|
2619
TAT Technologies
TATT
$540M
| $1.15M | ﹤0.01% |
201,300
+2,900
| +1% | +$17.9K |
|
2620
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.03B
| $1.14M | ﹤0.01% |
37,500
+5,000
| +15% | +$151K |
|
2621
Neurogene
NGNE
$709M
| $1.14M | ﹤0.01% |
24,144
+5,035
| +26% | +$259K |
|
|
BGG
2622
DELISTED
Briggs & Stratton Corp.
BGG
| $1.14M | ﹤0.01% |
111,200
-900
| -0.8% | -$10.1K |
|
|
ODT
2623
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.14M | ﹤0.01% |
31,000
+11,700
| +61% | +$280K |
|
|
PLYA
2624
DELISTED
Playa Hotels & Resorts
PLYA
| $1.13M | ﹤0.01% |
146,900
+94,200
| +179% | +$756K |
|
2625
iShares Global Tech ETF
IXN
$9.42B
| $1.13M | ﹤0.01% |
37,800
+22,200
| +142% | +$649K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.